Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Diabetes Metab ; 44(1): 61-72, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29174479

ABSTRACT

The use by diabetes patients of real-time continuous interstitial glucose monitoring (CGM) or the FreeStyle Libre® (FSL) flash glucose monitoring (FGM) system is becoming widespread and has changed diabetic practice. The working group bringing together a number of French experts has proposed the present practical consensus. Training of professionals and patient education are crucial for the success of CGM. Also, institutional recommendations must pay particular attention to the indications for and reimbursement of CGM devices in populations at risk of hypoglycaemia. The rules of good practice for CGM are the precursors of those that need to be enacted, given the oncoming emergence of artificial pancreas devices. It is necessary to have software combining user-friendliness, multiplatform usage and average glucose profile (AGP) presentation, while integrating glucose and insulin data as well as events. Expression of CGM data must strive for standardization that facilitates patient phenotyping and their follow-up, while integrating indicators of variability. The introduction of CGM involves a transformation of treatment support, rendering it longer and more complex as it also includes specific educational and technical dimensions. This complexity must be taken into account in discussions of organization of diabetes care.


Subject(s)
Blood Glucose Self-Monitoring , Patient Education as Topic , Practice Guidelines as Topic , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/therapy , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/therapy , France , Humans , Retrospective Studies
2.
Diabetes Metab ; 37(5): 395-402, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21478041

ABSTRACT

AIM: The aim of this study was to evaluate attitudes in hospital inpatients and physicians towards Ramadan fasting and diabetes in Marseille. METHODOLOGY: This cross-sectional study was conducted during the three months prior to the month of Ramadan. A total of 101 patients (age: 57±17 years) and 101 general practitioners (GPs) were recruited into the study. RESULTS: The patients had low levels of education (52% illiteracy). Of the 101 patients, 52 continued to fast during Ramadan, and only 65 patients had discussed the matter with their GP. Of these, 36 were told that fasting was forbidden, but more than half (n=19) fasted despite the medical advice. Six patients thus experienced daily hypoglycaemia because they had continued to take their hypoglycaemic agent or insulin analogue at noon. Both inadequate education and religious attitudes were found to endanger patients during the fast: 15 patients skipped the meal scheduled before dawn, five of whom persisted in taking their sulphonylurea. Also, 27% of patients refused, in spite of daytime hypoglycaemia, to ingest anything orally to avoid breaking their fast. Among the GP population, medical knowledge of Ramadan fasting with diabetes was low, leading to medically unjustified negative advice for fasting and a lack of patient education on adjusting treatments. This particular situation weakened the patient-physician relationship. CONCLUSION: This study confirms the importance of Ramadan fasting for Muslim patients, and reveals a wide cross-cultural gap between GPs and their patients. Systematic advice on treatment adjustment needs to be given. For this reason, we encourage more sensitive care of these patients and more medical training for physicians.


Subject(s)
Diabetes Mellitus, Type 1/psychology , Diabetes Mellitus, Type 2/psychology , Fasting/psychology , Holidays/psychology , Islam/psychology , Adult , Aged , Attitude of Health Personnel , Attitude to Health , Cross-Sectional Studies , Diabetes Mellitus, Type 1/diet therapy , Diabetes Mellitus, Type 1/ethnology , Diabetes Mellitus, Type 2/diet therapy , Diabetes Mellitus, Type 2/ethnology , Fasting/adverse effects , Female , France/epidemiology , General Practitioners/psychology , General Practitioners/statistics & numerical data , Humans , Inpatients/psychology , Inpatients/statistics & numerical data , Male , Middle Aged , Risk Factors , Surveys and Questionnaires
3.
Psychoneuroendocrinology ; 21(6): 525-43, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8983089

ABSTRACT

Acute psychological stress may play a role in the glycaemic instability of some patients with type I diabetes through an increased secretion of insulin-counteracting hormones. To examine the validity of this hypothesis, we subjected to a video-recorded public-speaking stress seven healthy persons, six type I diabetics with stable blood glucose levels and six type I diabetics with unstable or brittle diabetes (with more than 10 hypoglycaemia/month and frequent hyperglycaemia). During the test and on a control day, heart rate, blood pressure, plasma ACTH, cortisol, catecholamines and prolactin were measured. The comparison between the stable and unstable diabetics during the stress session by two-way analysis of variance (group/time) showed a significant difference for heart rate, blood pressure, ACTH and cortisol. Psychological interview showed that most unstable diabetics perceived a link between life stress and their blood glucose control. The unstable patients had much more difficulty in verbalizing their emotions. Our study shows that the two groups of diabetic patients display distinct cardiovascular and neuroendocrine responses to psychological stress, as well as distinct psychological profiles. In conclusion, hormonal response to an acute psychological stress is more pronounced in brittle diabetes and might be one of its pathogenic factors.


Subject(s)
Arousal/physiology , Blood Glucose/metabolism , Diabetes Mellitus, Type 1/physiopathology , Hormones/blood , Stress, Psychological/complications , Adolescent , Adrenocorticotropic Hormone/blood , Adult , Diabetes Mellitus, Type 1/psychology , Emotions/physiology , Epinephrine/blood , Female , Humans , Hydrocortisone/blood , Male , Middle Aged , Norepinephrine/blood , Prolactin/blood , Sick Role , Stress, Psychological/physiopathology
4.
Eur J Immunol ; 20(6): 1297-303, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2164479

ABSTRACT

In order to gain insight into the interaction between autoimmunity and viral infection in the onset of insulin-dependent diabetes, non-obese diabetic (NOD) mice which spontaneously develop autoimmune diabetes were inoculated with the diabetogenic variant of the encephalomyocarditis virus (EMCV-D) before the onset of the disease. The pre-diabetic period was divided into two phases: the early phase (days 88 to 116) during which development of spontaneous diabetes is rare and the late phase (day 123 to 200) during which the incidence of spontaneous diabetes is high. As controls ICR mice of common ancestry were also inoculated. During the early phase diabetes was observed in 4/10 inoculated, 0/13 control NOD and 7/13 inoculated ICR males vs. 6/12 inoculated, 1/11 control NOD and 0/15 inoculated ICR females. However, in NOD female, virus-induced diabetes prevalence was variable from one experiment to another. In parallel the flow cytometric analysis showed a high percentage of L3T4+ T lymphocytes in the pancreas of inoculated female NOD mice 10 days after the infection. At this time a large proportion of both L3T4+ and Ly-2+ cells expressed the interleukin 2 receptor. During the late phase no new case of diabetes occurred in inoculated NOD mice but one case was observed in control NOD males and five in control NOD females. This prevention of autoimmune diabetes was constantly found in other experiments. Insulitis was milder in inoculated NOD mice of both sexes than in control NOD. Adoptive transfer of diabetes into irradiated 8-week-old males by splenocytes from 28-week-old females was successful in five out seven attempts with control splenocytes and in zero out of six attempts with splenocytes from inoculated mice. This immunosuppression was specific as the ability of lymphocytes to respond to soluble or allogeneic antigens was preserved. In the early phase EMCV-D precipitated the onset of diabetes in females NOD mice by amplifying L3T4+ T lymphocyte-mediated immune mechanisms. During the late phase viral infection had lessened immune processes in animals which had resisted or recovered from virus-induced diabetes.


Subject(s)
Autoimmune Diseases/immunology , Diabetes Mellitus, Experimental/immunology , Diabetes Mellitus, Experimental/microbiology , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/microbiology , Enterovirus Infections/immunology , Animals , Cell Movement , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 1/pathology , Disease Susceptibility , Encephalomyocarditis virus , Enterovirus Infections/pathology , Female , Immunization, Passive , Lymphocyte Activation , Lymphocytes/physiology , Male , Mice , Pancreas/pathology , Phenotype , Spleen/pathology
5.
Metabolism ; 38(9): 913-5, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2505018

ABSTRACT

Epidemiologic data strongly suggest that upper distribution of body fat and high plasminogen activator inhibitor (PAI) activity are risk factors for cardiovascular disease. Therefore, a link between these two parameters was evaluated by studying 51 menstrually active nondiabetic obese women. In this group positive correlations were observed between body mass index (BMI), waist to hip circumference ratio (W/H ratio, which estimates body fat distribution), plasma insulin, and PAI activity. In addition, plasma triglycerides were related to the W/H ratio and insulin and PAI activity. Partial correlations revealed that BMI was independently and solely related to W/H ratio, which was also independently related to plasma insulin, which in turn related to PAI activity. These results suggest that upper body fat distribution acts as a risk factor of cardiovascular disease through its association with high PAI activity.


Subject(s)
Adipose Tissue , Obesity/metabolism , Plasminogen Activators/antagonists & inhibitors , Plasminogen Inactivators , Adolescent , Adult , Female , Humans , Insulin/blood , Middle Aged , Plasminogen Activators/metabolism , Risk Factors , Triglycerides/blood
6.
Diabete Metab ; 13(3 Pt 2): 331-6, 1987 Jul.
Article in English | MEDLINE | ID: mdl-3115843

ABSTRACT

Low fibrinolytic activity, as measured by euglobulin (EFA), has been observed in obese subjects, and hypofibrinolysis may play a role in the pathogenesis of atherosclerosis and its complications. Blood fibrinolytic activity is regulated through a complex system of activators and inhibitors, especially plasminogen activator inhibitors (PA Inhibitors). In a group of 35 non-diabetic subjects with a wide range of body mass index (BMI), EFA was negatively correlated, and PA Inhibitor activity positively correlated, with BMI and plasma insulin levels. In a population of 49 non-diabetic obese women (differing from a control group of normal weight by lower EFA and higher level, of PA Inhibitor activity, plasma insulin and triglyceride), the PA Inhibitor activity was positively correlated with BMI, insulin and triglyceride. The increase in PA Inhibitor activity was associated with a high value of PA Inhibitor 1 antigen measured by an immuno-radiometric assay, indicating that the increased activity was due to a high level of circulating PA Inhibitor 1. Plasma insulin was lowered in obese non-diabetic subjects, without modification of the body weight, by a 24 hour fast or by treatment with Metformin. After 24 hours' fast, ten obese subjects had lower levels of insulin and PA Inhibitor activity and an increase in EFA. Treatment for 15 days by 1.75 g Metformin (or placebo), on a weight maintaining diet, induced, in the Metformin group, a decrease in plasma insulin, triglyceride and PA Inhibitor activity and an increase in EFA, while no change was observed in the placebo group.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Glycoproteins/blood , Insulin/blood , Obesity/blood , Plasminogen Activators/antagonists & inhibitors , Plasminogen Inactivators , Triglycerides/blood , Adolescent , Adult , Female , Fibrinolysis , Humans , Male , Metformin/pharmacology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...